J3387 Injection elivaldogene autotemecel
J-Codes
Also known as: elivaldogene autotemcel, Hemarina, ex vivo gene therapy
Elivaldogene autotemcel (Hemarina) injection is a genetically modified patient's own T cells used for hemophilia A gene therapy.
Clinical Context
Gene therapy product for hemophilia A where patient T cells are modified ex vivo to express Factor VIII. Intravenous administration of engineered autologous T cells for sustained Factor VIII production.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.